Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 11 of 11 for “"TRIM5ALPHA"”.

  1. Host factors modulating HIV-1 infectivity and restriction

    … or even of CypA. A recent discovery identified TRIM5alpha as the factor mediating retroviral restriction in cells from mammalian species. While in non-human primates, TRIM5alpha potently blocks HIV-1, the human TRIM5alpha orthologue specifically targets N-tropic Murine Leukemia Virus (N-MLV). …

    fu-berlin Repository record for Host factors modulating HIV-1 infectivity and restriction (opens in a new tab)

  2. The function and diversity of the antiretroviral restriction factors TRIM5alpha and TRIMCyp in Old World primates

    The retroviral restriction factors TRIM5α and TRIMCyp, encoded in the <italic>TRIM5</italic> gene, prevent cross-species transmission of retroviruses in primates. In macaques (genus <italic>Macaca</italic>), TRIMCyp evolved through the retrotransposition of a cyclophilin A sequence into the …

    washington Repository record for The function and diversity of the antiretroviral restriction factors TRIM5alpha and TRIMCyp in Old World primates (opens in a new tab)

  3. The Role of Linker 2 (L2) Region in RhTRIM5α Assembly and HIV-1 Restriction

    The cellular restriction factor TRIM5alpha inhibits infection by numerous retroviruses in a species specific manner. TRIM5alpha protein from rhesus macaques (rhTRIM5alpha) and a related protein TRIM-Cyp from Owl monkeys restrict infection by HIV-1 while human TRIM5α (huTRIM5alpha) restricts …

    loyola-thes Repository record for The Role of Linker 2 (L2) Region in RhTRIM5α Assembly and HIV-1 Restriction (opens in a new tab)

  4. Gene therapy for HIV/AIDS: harnessing RNA interference and the restriction factor TRIM5alpha to inhibit HIV-1 infection

    HIV/AIDS continues to be a major public health problem worldwide with millions of people currently infected and new infections continuing to rise. As no effective vaccines are currently available for prevention, new and innovative therapies need to be developed. Current therapies such as highly …

    colostate Repository record for Gene therapy for HIV/AIDS: harnessing RNA interference and the restriction factor TRIM5alpha to inhibit HIV-1 infection (opens in a new tab)